Get the Stockscreener App
11.11
2.54%
-0.29
After Hours:
11.14
0.03
+0.27%
Engene Holdings Inc stock is traded at $11.11, with a volume of 152.31K.
It is down -2.54% in the last 24 hours and up +16.95% over the past month.
enGene Holdings Inc is a clinical-stage biotechnology company mainstreaming genetic medicine through the delivery of therapeutics to mucosal tissues and other organs, with the goal of creating new ways to address diseases with high clinical needs, beginning with non-muscle invasive bladder cancer (NMIBC). The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.
See More
Previous Close:
$11.40
Open:
$11.26
24h Volume:
152.31K
Relative Volume:
0.13
Market Cap:
$744.20M
Revenue:
-
Net Income/Loss:
$-103.21M
P/E Ratio:
-2.4152
EPS:
-4.6001
Net Cash Flow:
$-26.70M
1W Performance:
+22.09%
1M Performance:
+16.95%
6M Performance:
+200.27%
1Y Performance:
+64.11%
1-Day Range:
$10.96
$11.61
1-Week Range:
$9.01
$12.25
52-Week Range:
$2.65
$12.25
Engene Holdings Inc Stock (ENGN) Company Profile
Name
Engene Holdings Inc
Sector
Industry
Phone
(514) 332-4888
Address
4868 RUE LEVY, SUITE 220, SAINT-LAURENT
Compare ENGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ENGN
Engene Holdings Inc
|
11.11 | 763.63M | 0 | -103.21M | -26.70M | -4.6001 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.17 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.25 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
864.42 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
354.75 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
336.16 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Engene Holdings Inc Stock (ENGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-11-25 | Upgrade | Raymond James | Outperform → Strong Buy |
| Feb-18-25 | Initiated | Piper Sandler | Overweight |
| Feb-14-25 | Downgrade | UBS | Buy → Neutral |
| Dec-23-24 | Initiated | H.C. Wainwright | Buy |
| Nov-27-24 | Initiated | Raymond James | Outperform |
| Nov-18-24 | Initiated | JMP Securities | Mkt Outperform |
| Aug-28-24 | Initiated | Oppenheimer | Outperform |
| Apr-22-24 | Initiated | Wells Fargo | Overweight |
| Apr-15-24 | Initiated | Guggenheim | Buy |
| Mar-28-24 | Initiated | UBS | Buy |
| Mar-08-24 | Initiated | Morgan Stanley | Overweight |
| Feb-20-24 | Initiated | Leerink Partners | Outperform |
View All
Engene Holdings Inc Stock (ENGN) Latest News
enGene: Two Major Catalysts On Deck For 2nd Half Of 2026 (NASDAQ:ENGN) - Seeking Alpha
enGene Holdings Closes $130 Million Public Offering - MSN
EnGene extends momentum with another 14% surge on Friday - MSN
Trend Recap: Is HBTA a cyclical or defensive stockMarket Growth Review & Real-Time Chart Breakout Alerts - baoquankhu1.vn
Short Squeeze: Is enGene Holdings Inc stock a good dividend stockJuly 2025 Big Picture & High Accuracy Investment Signals - baoquankhu1.vn
enGene extends momentum with another 14% surge on Friday (ENGN:NASDAQ) - Seeking Alpha
enGene (NASDAQ:ENGN) Hits New 1-Year HighStill a Buy? - MarketBeat
Profit Recap: What analysts say about enGene Holdings Inc Equity Warrant stockPortfolio Risk Summary & Capital Efficiency Focused Strategies - baoquankhu1.vn
enGene (NASDAQ:ENGN) Stock Price Up 11.3%Time to Buy? - MarketBeat
Aug Reactions: Is Heritage Financial Corporation a speculative investmentWeekly Risk Summary & Expert Approved Momentum Ideas - baoquankhu1.vn
enGene (NASDAQ:ENGN) Sees Strong Trading VolumeWhat's Next? - MarketBeat
enGene Holdings (NASDAQ: ENGN) adds $125M debt facility and new warrants - Stock Titan
Breakout Watch: Is enGene Holdings Inc. benefiting from interest rate changesJuly 2025 EndofMonth & Verified Swing Trading Watchlist - baoquankhu1.vn
enGene Announces Expanded $125 Million Debt Facility with Hercules Capital, Inc. - PharmiWeb.com
Weekly Trades: Does enGene Holdings Inc Equity Warrant stock benefit from AI growth2025 Macro Impact & Safe Swing Trade Setup Alerts - baoquankhu1.vn
enGene Announces Expanded $125 Million Debt Facility with Hercules Capital - citybiz
enGene Holdings Secures $125 Million Loan Agreement with Hercules Capital - Intellectia AI
Meme Stocks: Is enGene Holdings Inc benefiting from interest rate changesJuly 2025 Rallies & Verified Entry Point Signals - baoquankhu1.vn
Is enGene Holdings Inc. a strong growth stockPortfolio Allocation Tips & Free Tap Rapid Wealth - bollywoodhelpline.com
Targets Report: Will HITI benefit from geopolitical trendsQuarterly Market Review & Safe Capital Preservation Plans - baoquankhu1.vn
enGene Holdings Inc. (NASDAQ:ENGN) Short Interest Up 32.4% in December - MarketBeat
Aug Summary: Will PCRX announce a stock splitAnalyst Downgrade & Verified Chart Pattern Trade Signals - baoquankhu1.vn
Portfolio Update: Can enGene Holdings Inc benefit from deglobalizationJuly 2025 PostEarnings & Risk Managed Trade Strategies - baoquankhu1.vn
AI Stocks: What drives enGene Holdings Inc Equity Warrants stock price2025 Historical Comparison & Step-by-Step Trade Execution Guides - baoquankhu1.vn
Quarterly Recap: Is enGene Holdings Inc benefiting from interest rate changesQuarterly Portfolio Report & High Return Stock Watch Alerts - baoquankhu1.vn
enGene (NASDAQ:ENGN) Sees Large Volume IncreaseStill a Buy? - MarketBeat
Does enGene Holdings Inc outperform in volatile markets2025 Year in Review & Growth Focused Entry Reports - baoquankhu1.vn
Growth Report: Is enGene Holdings Inc Equity Warrant impacted by rising ratesTrade Risk Assessment & Real-Time Stock Entry Alerts - baoquankhu1.vn
Stock Market Recap: What analysts say about ACON stockTrade Performance Summary & Free High Return Stock Watch Alerts - baoquankhu1.vn
How resilient is enGene Holdings Inc. Equity Warrant stock in market downturnsJuly 2025 Reactions & Weekly High Potential Alerts - Улправда
enGene Holdings Inc. (NASDAQ:ENGN) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Short Covering: Is enGene Holdings Inc. Equity Warrant stock a dividend growth opportunity2025 Growth vs Value & Community Trade Idea Sharing - Улправда
Aug Highlights: Can enGene Holdings Inc Equity Warrant stock sustain free cash flow growth2025 Pullback Review & Consistent Income Trade Recommendations - Bộ Nội Vụ
Can enGene Holdings Inc. stock double in next 5 yearsNew Guidance & Safe Entry Momentum Stock Tips - Улправда
How enGene Holdings Inc. stock performs in high volatility markets2025 Price Targets & Weekly High Potential Stock Alerts - ulpravda.ru
How geopolitical tensions affect enGene Holdings Inc. Equity Warrant stockQuarterly Market Summary & High Yield Stock Recommendations - Улправда
Is enGene Holdings Inc. Equity Warrant stock a dividend growth opportunityTrade Performance Summary & Growth-Oriented Investment Plans - Улправда
Will enGene Holdings Inc. stock benefit from AI adoption2025 Price Momentum & Daily Stock Trend Watchlist - ulpravda.ru
Is enGene Holdings Inc. stock safe for conservative investorsJuly 2025 Gainers & Reliable Price Action Trade Plans - Улправда
Is enGene Holdings Inc. stock a contrarian buy2025 Retail Activity & Consistent Income Trade Recommendations - Улправда
Operating cash flow per share of enGene Holdings Inc. Warranton enGene Holdings – NASDAQ:ENGNW - TradingView — Track All Markets
enGene (NASDAQ:ENGN) Stock Price Up 7%Still a Buy? - MarketBeat
enGene Holdings Inc Stock Analysis and ForecastValue Traps to Avoid & Hidden Gems with Outstanding Profit Margins - earlytimes.in
Citizens reiterates Market Outperform rating on Engene stock with $21 target - Investing.com Nigeria
Citizens reiterates Market Outperform rating on Engene stock with $21 target By Investing.com - Investing.com South Africa
Piper Sandler Initiates Coverage of enGene Holdings (ENGN) with Overweight Recommendation - MSN
enGene (NASDAQ:ENGN) Shares Gap Up – Should You Buy? - Defense World
enGene (NASDAQ:ENGN) Shares Gap UpStill a Buy? - MarketBeat
enGene Holdings: A Potential Oncology Entrant (NASDAQ:ENGN) - Seeking Alpha
ETFs Investing in enGene Holdings Inc. Stocks - TradingView — Track All Markets
While Institutions Invested in EnGene Holdings Inc. (NASDAQ:ENGN) Benefited From Last Week's 21% Gain, Private Equity Firms Stood to Gain the Most - 富途牛牛
Engene Holdings Inc Stock (ENGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.09%
0.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):